Verastem Oncology
VSTM
#7283
Rank
โ‚ฌ0.41 B
Marketcap
5,51ย โ‚ฌ
Share price
-1.35%
Change (1 day)
-0.39%
Change (1 year)

Revenue for Verastem Oncology (VSTM)

Revenue in 2025 (TTM): โ‚ฌ11.39 Million

According to Verastem Oncology 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ11.23 Million. In 2024 the company made a revenue of โ‚ฌ9.6 Million an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verastem Oncology from 2011 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ11.39 M18.55%
2024 โ‚ฌ9.6 M
2023 N/A-100%
2022 โ‚ฌ2.42 M33.5%
2021 โ‚ฌ1.81 M-97.48%
2020 โ‚ฌ71.96 M361.86%
2019 โ‚ฌ15.58 M-33.28%
2018 โ‚ฌ23.35 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚ฌ52.70 B 469,187.69%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ11.55 B 102,787.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ35.55 B 316,461.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
โ‚ฌ9.77 M-12.92%๐Ÿ‡บ๐Ÿ‡ธ USA